Cargando…
Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s Disease
Introduction. A growing literature has developed on identifying outcomes that matter to patients. This study demonstrates an approach involving patient and regulatory perspectives to identify outcomes that are meaningful in the context of medical devices for Parkinson’s disease (PD). Methods. A syst...
Autores principales: | Benz, Heather L., Caldwell, Brittany, Ruiz, John P., Saha, Anindita, Ho, Martin, Christopher, Stephanie, Bardot, Dawn, Sheehan, Margaret, Donnelly, Anne, McLaughlin, Lauren, Mange, Brennan, Hauber, A. Brett, Gwinn, Katrina, Heetderks, William J., Sheldon, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255597/ https://www.ncbi.nlm.nih.gov/pubmed/34277950 http://dx.doi.org/10.1177/23814683211021380 |
Ejemplares similares
-
Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for
Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered
Threshold Technique Study
por: Hauber, Brett, et al.
Publicado: (2021) -
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
por: Cohen, S., et al.
Publicado: (2022) -
Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
por: Campbell, Belinda A., et al.
Publicado: (2020) -
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices
por: Boeri, Marco, et al.
Publicado: (2019) -
Cervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvements
por: Bond, Lisa M., et al.
Publicado: (2014)